Paid

GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.

With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.

American Diabetes Association symposium presents new phase 3 clinical trials of SURPASS-3 and SURPASS-5. 

Real-world data for the Medtronic Extended-Wear Infusion Set revealed at the 81st American Diabetes Association scientific session.

American Diabetes Association mini-symposium presented by Biykem Bozkurt, MD, Ph.D., FHFSA, FACC, FAHA, FESC. 

People who reported two or more servings per week of oily fish consumption had a 22% lower risk of developing type 2 diabetes.

Older adults may be at risk of adverse events such as hypoglycemia when overtreated with certain medications. 

A cohort study evaluated the relationship between the severity of newly diagnosed diabetic retinopathy in adult patients and the incidence of progression to sustained blindness. 

A century after the discovery of insulin, new insulins, new devices, and other innovations may again change the future of treatment for type 1 diabetes.